India Panel Favors Favipiravir, Tocilizumab As It Assesses COVID-19 Treatments

Strides Begins Favipiravir Exports, Glenmark to Start Trials

 
• By Vibha Ravi
  
Coronavirus_Boxing_Glove
India Builds Defenses With Multiple COVID-19 Drug Candidates • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip